• 

  7 Things to Know About New Alzheimer’s Drug Kisunla
• 

  Considering Enrolling in a Dementia Clinical Trial? 6 Things You Should Know
• 

  FDA Approves New Alzheimer’s Drug Kisunla (Donanemab)
• 

  Why the ADDF Is Betting $5M on This Experimental Alzheimer’s Drug
• 

  A Pill to Slow Down Alzheimer’s Is as Little as a Year Away
• 

  FDA Advisory Committee Recommends Approval of New Alzheimer’s Drug
• 

  Annovis Bio’s Experimental Alzheimer’s Capsule Falls Short in Latest Trial
• 

  Tau Protein: Coming to New Alzheimer’s Diagnostics and Treatments Near You
• 

  Alzheimer’s Rates Are Highest In These Counties—But No Leqembi Access
• 

  Alzheimer’s Drug Types 101: What Are Biologics?
• 

  Alzheimer’s Drug Types 101: What Are Small Molecule Drugs?
• 

  ‘Blue Pee’ Saga Continues: Scientists Still Skeptical About TauRx Alzheimer’s Pill
• 

  ‘A Time of Hope’: Experts on Alzheimer’s Drug Breakthroughs
• 

  Why Are Alzheimer’s Drugs So Slow to Come? A Pharmacy Expert Explains
• 

  TRIALS UPDATE: The Latest Alzheimer’s Clinical Trial News (2024.01)

Previous567Next